Thalassemia Summary Interpretation, Blood
Use
This test provides a summary interpretation of thalassemia and hemoglobinopathy evaluations, incorporating molecular testing results. It assists in diagnosing complex hemoglobin disorders involving multiple genetic variants across alpha, beta, delta, and gamma genes. The test is valuable for ordering physicians, as it integrates various test results into a comprehensive evaluation to guide clinical decision-making.
Special Instructions
Not provided.
Limitations
The test focuses on providing a consultative interpretation of the thalassemia evaluation and may not capture all potential genetic variations impacting hemoglobin functionality. It requires results from prior molecular testing and cannot serve as a standalone diagnosis without these integrated results.
New York Approved
Methodology
Other
Biomarkers
LOINC Codes
- 14869-2 - Path Rev Bld -Imp
- 14869-2 - Path Rev Bld -Imp
- 18771-6 - Provider signing name
Result Turnaround Time
3-25 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided
Container
EDTA
Storage Instructions
Refrigerated